106 related articles for article (PubMed ID: 6883930)
21. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
22. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
23. Effect of altered serum protein binding on propranolol distribution into milk in the lactating rabbit.
Fleishaker JC; McNamara PJ
J Pharmacol Exp Ther; 1988 Mar; 244(3):925-8. PubMed ID: 3252038
[TBL] [Abstract][Full Text] [Related]
24. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
25. Clearance of vancomycin during high-efficiency hemodialysis.
Klansuwan N; Ratanajamit C; Kasiwong S; Wangsiripaisan A
J Med Assoc Thai; 2006 Jul; 89(7):986-91. PubMed ID: 16881431
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of furosemide in patients on peritoneal dialysis.
Flinn A; Ledger S; Blake P
CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
[TBL] [Abstract][Full Text] [Related]
27. Clearance of 131I by hemodialysis.
Culpepper RM; Hirsch JI; Fratkin MJ
Clin Nephrol; 1992 Aug; 38(2):110-4. PubMed ID: 1516279
[TBL] [Abstract][Full Text] [Related]
28. Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients.
van Olden RW; van Acker BA; Koomen GC; Krediet RT; Arisz L
Clin Nephrol; 1998 Mar; 49(3):167-72. PubMed ID: 9543598
[TBL] [Abstract][Full Text] [Related]
29. Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
Oie S; Fiori F; Chiang J
J Pharmacol Exp Ther; 1987 Jun; 241(3):934-8. PubMed ID: 3598910
[TBL] [Abstract][Full Text] [Related]
30. Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal Disease.
Pai SM; Yamada H
Clin Pharmacol Drug Dev; 2021 May; 10(5):463-470. PubMed ID: 33788422
[TBL] [Abstract][Full Text] [Related]
31. Hemodialysis clearance of cimetidine.
Vaziri ND; Ness RL; Barton CH
Arch Intern Med; 1978 Nov; 138(11):1685-6. PubMed ID: 718319
[TBL] [Abstract][Full Text] [Related]
32. Clearance of lidocaine by hemodialysis.
Vaziri ND; Saiki JK; Hughes W
South Med J; 1979 Dec; 72(12):1567-8. PubMed ID: 515769
[TBL] [Abstract][Full Text] [Related]
33. Effect of change in blood flow on hemodialysis clearance studied by a simple unified organ clearance approach.
Chiou WL; Lee HJ
Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):393-6. PubMed ID: 2813959
[TBL] [Abstract][Full Text] [Related]
34. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
[TBL] [Abstract][Full Text] [Related]
35. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
Kettner W; Banditt P; Walther H
Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
[TBL] [Abstract][Full Text] [Related]
36. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
Lee CS; Marbury TC; Benet LZ
J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
[TBL] [Abstract][Full Text] [Related]
37. Rapid estimation of unbound lidocaine clearance in cardiac patients: implications for reducing toxicity.
Denson DD; Toltzis RJ; Ernst TF; Youngs CH; Thomas RL; Grummich KW
J Clin Pharmacol; 1988 Nov; 28(11):995-1000. PubMed ID: 3243921
[TBL] [Abstract][Full Text] [Related]
38. Lidocaine plasma protein binding.
Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
[TBL] [Abstract][Full Text] [Related]
39. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
Wang LH; Lee CS; Majeske BL; Marbury TC
Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
[TBL] [Abstract][Full Text] [Related]
40. Hemodialysis clearance of chloroquine in uremic patients.
Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
